These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 19711435)

  • 1. Flow cytometric detection of Ewing sarcoma cells in peripheral blood and bone marrow.
    Dubois SG; Epling CL; Teague J; Matthay KK; Sinclair E
    Pediatr Blood Cancer; 2010 Jan; 54(1):13-8. PubMed ID: 19711435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of detection of CD99
    Zakzok O; Elshanshory M; Zekri W; Elsharkawy N; Zaky I; Salama A; Kamel A; Elantably I; Said S
    Pediatr Blood Cancer; 2022 Jan; 69(1):e29298. PubMed ID: 34403190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Two Measures of Micrometastatic Disease on Clinical Outcomes in Patients with Newly Diagnosed Ewing Sarcoma: A Report from the Children's Oncology Group.
    Vo KT; Edwards JV; Epling CL; Sinclair E; Hawkins DS; Grier HE; Janeway KA; Barnette P; McIlvaine E; Krailo MD; Barkauskas DA; Matthay KK; Womer RB; Gorlick RG; Lessnick SL; Mackall CL; DuBois SG
    Clin Cancer Res; 2016 Jul; 22(14):3643-50. PubMed ID: 26861456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted imaging of Ewing sarcoma in preclinical models using a 64Cu-labeled anti-CD99 antibody.
    O'Neill AF; Dearling JL; Wang Y; Tupper T; Sun Y; Aster JC; Calicchio ML; Perez-Atayde AR; Packard AB; Kung AL
    Clin Cancer Res; 2014 Feb; 20(3):678-87. PubMed ID: 24218512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-30a-5p connects EWS-FLI1 and CD99, two major therapeutic targets in Ewing tumor.
    Franzetti GA; Laud-Duval K; Bellanger D; Stern MH; Sastre-Garau X; Delattre O
    Oncogene; 2013 Aug; 32(33):3915-21. PubMed ID: 22986530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC; Dunphy CH
    Arch Pathol Lab Med; 2006 Feb; 130(2):153-7. PubMed ID: 16454553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical detection of FLI-1 protein expression: a study of 132 round cell tumors with emphasis on CD99-positive mimics of Ewing's sarcoma/primitive neuroectodermal tumor.
    Folpe AL; Hill CE; Parham DM; O'Shea PA; Weiss SW
    Am J Surg Pathol; 2000 Dec; 24(12):1657-62. PubMed ID: 11117787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Application of the in situ hybridization with EWS dual-color break-apart fluorescence probe and anti-CD99 and anti-FLI-1 antibodies in the diagnosis of Ewing's sarcoma/primitive neuroectodermal tumor].
    Liu BY; Yang Y; DU J; Zhang Y; Wang H; Zheng J
    Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):358-62. PubMed ID: 18677380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry for PAX7 is a useful confirmatory marker for Ewing sarcoma in decalcified bone marrow core biopsy specimens.
    Fernandez-Pol S; van de Rijn M; Natkunam Y; Charville GW
    Virchows Arch; 2018 Dec; 473(6):765-769. PubMed ID: 30014288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of the heterogeneity of prognostic cellular biomarkers in ewing sarcoma using automated image and random survival forest analysis.
    Bühnemann C; Li S; Yu H; Branford White H; Schäfer KL; Llombart-Bosch A; Machado I; Picci P; Hogendoorn PC; Athanasou NA; Noble JA; Hassan AB
    PLoS One; 2014; 9(9):e107105. PubMed ID: 25243408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary orbital Ewing sarcoma in a middle-aged woman.
    Choi RY; Lucarelli MJ; Imesch PD; Hafez GR; Albert DM; Dortzbach RK
    Arch Ophthalmol; 1999 Apr; 117(4):535-7. PubMed ID: 10206587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MIC-2 positive granulocytic sarcoma of ulna mimicking Ewing sarcoma.
    Prakash G; Ganesan P; Ahuja A; Bakhshi S
    Pediatr Blood Cancer; 2008 Dec; 51(6):836-7. PubMed ID: 18680149
    [No Abstract]   [Full Text] [Related]  

  • 13. A new sensitive and specific combination of CD81/CD56/CD45 monoclonal antibodies for detecting circulating neuroblastoma cells in peripheral blood using flow cytometry.
    Nagai J; Ishida Y; Koga N; Tanaka Y; Ohnuma K; Toyoda Y; Katoh A; Hayabuchi Y; Kigasawa H
    J Pediatr Hematol Oncol; 2000; 22(1):20-6. PubMed ID: 10695817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.
    Rocchi A; Manara MC; Sciandra M; Zambelli D; Nardi F; Nicoletti G; Garofalo C; Meschini S; Astolfi A; Colombo MP; Lessnick SL; Picci P; Scotlandi K
    J Clin Invest; 2010 Mar; 120(3):668-80. PubMed ID: 20197622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple multicolor flow cytometry protocol for detection and molecular characterization of circulating tumor cells in epithelial cancers.
    Hristozova T; Konschak R; Budach V; Tinhofer I
    Cytometry A; 2012 Jun; 81(6):489-95. PubMed ID: 22438318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of FLI-1 monoclonal antibody and dual-colour, break-apart probe fluorescence in situ (FISH) analysis in Ewing's sarcoma/primitive neuroectodermal tumour (EWS/PNET). A comparative study with CD99 and FLI-1 polyclonal antibodies.
    Mhawech-Fauceglia P; Herrmann F; Penetrante R; Beck A; Sait S; Block AM; Odunsi K; Fisher J; Balos L; Cheney RT
    Histopathology; 2006 Dec; 49(6):569-75. PubMed ID: 17163841
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of human single-chain antibody to the CD99 cell surface determinant specifically recognizing Ewing's sarcoma tumor cells.
    Gellini M; Ascione A; Flego M; Mallano A; Dupuis ML; Zamboni S; Terrinoni M; D'Alessio V; Manara MC; Scotlandi K; Picci P; Cianfriglia M
    Curr Pharm Biotechnol; 2013; 14(4):449-63. PubMed ID: 22335486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD99 engagement: an effective therapeutic strategy for Ewing tumors.
    Scotlandi K; Baldini N; Cerisano V; Manara MC; Benini S; Serra M; Lollini PL; Nanni P; Nicoletti G; Bernard G; Bernard A; Picci P
    Cancer Res; 2000 Sep; 60(18):5134-42. PubMed ID: 11016640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Round cell sarcoma with CIC-DUX4 gene fusion: Discussion of the distinctive cytomorphologic, immunohistochemical, and molecular features in the differential diagnosis of round cell tumors.
    Chebib I; Jo VY
    Cancer Cytopathol; 2016 May; 124(5):350-61. PubMed ID: 26800124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of Nucleosidic CD99 inhibitors that selectively reduce Ewing sarcoma viability.
    Balaraman K; Deniz E; Nelson E; Pilicer SL; Atasoy S; Molotkova A; Sevim H; Tiwari PB; Üren A; Wolf C
    Eur J Med Chem; 2023 May; 251():115244. PubMed ID: 36917882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.